APO Research
Talk to an analyst

APO RESEARCH · REPORT

CAR T-Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global CAR T-Cell Therapy Industry Growth and Trends Forecast to 2032

28 December 2025103 pages

Choose your research edition.

Industry ResearchCAR T-Cell Therapy Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal CAR T-Cell Therapy Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal CAR T-Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CAR T-Cell Therapy Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal CAR T-Cell Therapy Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global CAR T-Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for CAR T-Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for CAR T-Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CAR T-Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the CAR T-Cell Therapy market include J & J, Novartis, Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), JW Therapeutics, Gilead Sciences, FOSUNKite, Celyad(Pipeline) and Cellectis(Pipeline), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global CAR T-Cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The CAR T-Cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CAR T-Cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CAR T-Cell Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global CAR T-Cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

CAR T-Cell Therapy Market by Company

J & J

Novartis

Sorrento Therapeutics(Pipeline)

Mustang Bio(Pipeline)

JW Therapeutics

Gilead Sciences

FOSUNKite

Celyad(Pipeline)

Cellectis(Pipeline)

CARsgen Therapeutics (Pipeline)

Bristol-Myers Squibb

Bluebird Bio(Pipeline)

Autolus Therapeutics(Pipeline)

Allogene Therapeutics(Pipeline)

CAR T-Cell Therapy Segment by Type

CD19 - Targeted

BCMA - Targeted

CAR T-Cell Therapy Segment by Application

Lymphoma

Multiple Myeloma

CAR T-Cell Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR T-Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CAR T-Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR T-Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of CAR T-Cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global CAR T-Cell Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global CAR T-Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global CAR T-Cell Therapy Market Share by Region (2021-2026) Table 4. Global CAR T-Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global CAR T-Cell Therapy Market Share by Region (2027-2032) Table 6. Global CAR T-Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global CAR T-Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global CAR T-Cell Therapy Market Size Share by Type (2021-2026) Table 9. Global CAR T-Cell Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global CAR T-Cell Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America CAR T-Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe CAR T-Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific CAR T-Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America CAR T-Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa CAR T-Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global CAR T-Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global CAR T-Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global CAR T-Cell Therapy Market Size Share by Application (2021-2026) Table 24. Global CAR T-Cell Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global CAR T-Cell Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America CAR T-Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe CAR T-Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific CAR T-Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America CAR T-Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa CAR T-Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. CAR T-Cell Therapy Industry Trends Table 37. CAR T-Cell Therapy Industry Drivers Table 38. CAR T-Cell Therapy Industry Opportunities and Challenges Table 39. CAR T-Cell Therapy Industry Restraints Table 40. Global CAR T-Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global CAR T-Cell Therapy Revenue Market Share by Company (2021-2026) Table 42. Global CAR T-Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global CAR T-Cell Therapy Key Company Headquarters & Area Served Table 44. Global CAR T-Cell Therapy Company, Product Type & Application Table 45. Global CAR T-Cell Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. J & J Company Information Table 49. J & J Business Overview Table 50. J & J CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. J & J CAR T-Cell Therapy Product Portfolio Table 52. J & J Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis CAR T-Cell Therapy Product Portfolio Table 57. Novartis Recent Development Table 58. Sorrento Therapeutics(Pipeline) Company Information Table 59. Sorrento Therapeutics(Pipeline) Business Overview Table 60. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio Table 62. Sorrento Therapeutics(Pipeline) Recent Development Table 63. Mustang Bio(Pipeline) Company Information Table 64. Mustang Bio(Pipeline) Business Overview Table 65. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Mustang Bio(Pipeline) CAR T-Cell Therapy Product Portfolio Table 67. Mustang Bio(Pipeline) Recent Development Table 68. JW Therapeutics Company Information Table 69. JW Therapeutics Business Overview Table 70. JW Therapeutics CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. JW Therapeutics CAR T-Cell Therapy Product Portfolio Table 72. JW Therapeutics Recent Development Table 73. Gilead Sciences Company Information Table 74. Gilead Sciences Business Overview Table 75. Gilead Sciences CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Gilead Sciences CAR T-Cell Therapy Product Portfolio Table 77. Gilead Sciences Recent Development Table 78. FOSUNKite Company Information Table 79. FOSUNKite Business Overview Table 80. FOSUNKite CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. FOSUNKite CAR T-Cell Therapy Product Portfolio Table 82. FOSUNKite Recent Development Table 83. Celyad(Pipeline) Company Information Table 84. Celyad(Pipeline) Business Overview Table 85. Celyad(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Celyad(Pipeline) CAR T-Cell Therapy Product Portfolio Table 87. Celyad(Pipeline) Recent Development Table 88. Cellectis(Pipeline) Company Information Table 89. Cellectis(Pipeline) Business Overview Table 90. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Cellectis(Pipeline) CAR T-Cell Therapy Product Portfolio Table 92. Cellectis(Pipeline) Recent Development Table 93. CARsgen Therapeutics (Pipeline) Company Information Table 94. CARsgen Therapeutics (Pipeline) Business Overview Table 95. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Portfolio Table 97. CARsgen Therapeutics (Pipeline) Recent Development Table 98. Bristol-Myers Squibb Company Information Table 99. Bristol-Myers Squibb Business Overview Table 100. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bristol-Myers Squibb CAR T-Cell Therapy Product Portfolio Table 102. Bristol-Myers Squibb Recent Development Table 103. Bluebird Bio(Pipeline) Company Information Table 104. Bluebird Bio(Pipeline) Business Overview Table 105. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Portfolio Table 107. Bluebird Bio(Pipeline) Recent Development Table 108. Autolus Therapeutics(Pipeline) Company Information Table 109. Autolus Therapeutics(Pipeline) Business Overview Table 110. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio Table 112. Autolus Therapeutics(Pipeline) Recent Development Table 113. Allogene Therapeutics(Pipeline) Company Information Table 114. Allogene Therapeutics(Pipeline) Business Overview Table 115. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio Table 117. Allogene Therapeutics(Pipeline) Recent Development Table 118. North America CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America CAR T-Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 120. North America CAR T-Cell Therapy Market Share by Country (2021-2026) Table 121. North America CAR T-Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America CAR T-Cell Therapy Market Share Forecast by Country (2027-2032) Table 123. Europe CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe CAR T-Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe CAR T-Cell Therapy Market Share by Country (2021-2026) Table 126. Europe CAR T-Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe CAR T-Cell Therapy Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific CAR T-Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific CAR T-Cell Therapy Market Share by Country (2021-2026) Table 131. Asia-Pacific CAR T-Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific CAR T-Cell Therapy Market Share Forecast by Country (2027-2032) Table 133. Latin America CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America CAR T-Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America CAR T-Cell Therapy Market Share by Country (2021-2026) Table 136. Latin America CAR T-Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America CAR T-Cell Therapy Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa CAR T-Cell Therapy Market Share by Country (2021-2026) Table 141. Middle East & Africa CAR T-Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa CAR T-Cell Therapy Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. CAR T-Cell Therapy Product Image Figure 3. Global CAR T-Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global CAR T-Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global CAR T-Cell Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global CAR T-Cell Therapy Market Share by Region (2021-2032) Figure 7. North America CAR T-Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe CAR T-Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America CAR T-Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CD19 - Targeted Image Figure 13. Global CD19 - Targeted Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. BCMA - Targeted Image Figure 15. Global BCMA - Targeted Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global CAR T-Cell Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global CAR T-Cell Therapy Market Share by Type 2025 VS 2032 Figure 18. North America CAR T-Cell Therapy Market Size Share by Type (2021-2032) Figure 19. Europe CAR T-Cell Therapy Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific CAR T-Cell Therapy Market Size Share by Type (2021-2032) Figure 21. Latin America CAR T-Cell Therapy Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa CAR T-Cell Therapy Market Size Share by Type (2021-2032) Figure 23. Lymphoma Image Figure 24. Global Lymphoma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Multiple Myeloma Image Figure 26. Global Multiple Myeloma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global CAR T-Cell Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global CAR T-Cell Therapy Market Share by Application 2025 VS 2032 Figure 29. North America CAR T-Cell Therapy Market Size Share by Application (2021-2032) Figure 30. Europe CAR T-Cell Therapy Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific CAR T-Cell Therapy Market Size Share by Application (2021-2032) Figure 32. Latin America CAR T-Cell Therapy Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa CAR T-Cell Therapy Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 CAR T-Cell Therapy Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America CAR T-Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America CAR T-Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America CAR T-Cell Therapy Market Share by Country (2021-2032) Figure 39. Europe CAR T-Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe CAR T-Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe CAR T-Cell Therapy Market Share by Country (2021-2032) Figure 42. Asia-Pacific CAR T-Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific CAR T-Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific CAR T-Cell Therapy Market Share by Country (2021-2032) Figure 45. Latin America CAR T-Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America CAR T-Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America CAR T-Cell Therapy Market Share by Country (2021-2032) Figure 48. Middle East & Africa CAR T-Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa CAR T-Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa CAR T-Cell Therapy Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • CD19 - Targeted
  • BCMA - Targeted
Applications
  • Lymphoma
  • Multiple Myeloma
Companies covered
  • J & J
  • Novartis
  • Sorrento Therapeutics(Pipeline)
  • Mustang Bio(Pipeline)
  • JW Therapeutics
  • Gilead Sciences
  • FOSUNKite
  • Celyad(Pipeline)
  • Cellectis(Pipeline)
  • CARsgen Therapeutics (Pipeline)
  • Bristol-Myers Squibb
  • Bluebird Bio(Pipeline)
  • Autolus Therapeutics(Pipeline)
  • Allogene Therapeutics(Pipeline)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global CAR T-Cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global CAR T-Cell Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global CAR T-Cell Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global CAR T-Cell Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions CAR T-Cell Therapy Market Size (2021-2032)
  8. 1.5.1 North America CAR T-Cell Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe CAR T-Cell Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America CAR T-Cell Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate (2021-2032)
2 CAR T-Cell Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CD19 - Targeted
  3. 2.1.2 BCMA - Targeted
  4. 2.2 Global CAR T-Cell Therapy Market Size by Type
  5. 2.2.1 Global CAR T-Cell Therapy Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global CAR T-Cell Therapy Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global CAR T-Cell Therapy Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global CAR T-Cell Therapy Market Size by Regions
  9. 2.3.1 North America CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa CAR T-Cell Therapy Market Size Breakdown by Type (2021-2026)
3 CAR T-Cell Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Lymphoma
  3. 3.1.2 Multiple Myeloma
  4. 3.2 Global CAR T-Cell Therapy Market Size by Application
  5. 3.2.1 Global CAR T-Cell Therapy Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global CAR T-Cell Therapy Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global CAR T-Cell Therapy Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global CAR T-Cell Therapy Market Size by Regions
  9. 3.3.1 North America CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa CAR T-Cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 CAR T-Cell Therapy Industry Trends
  2. 4.2 CAR T-Cell Therapy Industry Drivers
  3. 4.3 CAR T-Cell Therapy Industry Opportunities and Challenges
  4. 4.4 CAR T-Cell Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by CAR T-Cell Therapy Revenue (2021-2026)
  2. 5.2 Global CAR T-Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global CAR T-Cell Therapy Key Company Headquarters & Area Served
  4. 5.4 Global CAR T-Cell Therapy Company, Product Type & Application
  5. 5.5 Global CAR T-Cell Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global CAR T-Cell Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 CAR T-Cell Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 CAR T-Cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 J & J
  2. 6.1.1 J & J Company Information
  3. 6.1.2 J & J Business Overview
  4. 6.1.3 J & J CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 J & J CAR T-Cell Therapy Product Portfolio
  6. 6.1.5 J & J Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis CAR T-Cell Therapy Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Sorrento Therapeutics(Pipeline)
  14. 6.3.1 Sorrento Therapeutics(Pipeline) Company Information
  15. 6.3.2 Sorrento Therapeutics(Pipeline) Business Overview
  16. 6.3.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
  18. 6.3.5 Sorrento Therapeutics(Pipeline) Recent Developments
  19. 6.4 Mustang Bio(Pipeline)
  20. 6.4.1 Mustang Bio(Pipeline) Company Information
  21. 6.4.2 Mustang Bio(Pipeline) Business Overview
  22. 6.4.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Portfolio
  24. 6.4.5 Mustang Bio(Pipeline) Recent Developments
  25. 6.5 JW Therapeutics
  26. 6.5.1 JW Therapeutics Company Information
  27. 6.5.2 JW Therapeutics Business Overview
  28. 6.5.3 JW Therapeutics CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 JW Therapeutics CAR T-Cell Therapy Product Portfolio
  30. 6.5.5 JW Therapeutics Recent Developments
  31. 6.6 Gilead Sciences
  32. 6.6.1 Gilead Sciences Company Information
  33. 6.6.2 Gilead Sciences Business Overview
  34. 6.6.3 Gilead Sciences CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Gilead Sciences CAR T-Cell Therapy Product Portfolio
  36. 6.6.5 Gilead Sciences Recent Developments
  37. 6.7 FOSUNKite
  38. 6.7.1 FOSUNKite Company Information
  39. 6.7.2 FOSUNKite Business Overview
  40. 6.7.3 FOSUNKite CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 FOSUNKite CAR T-Cell Therapy Product Portfolio
  42. 6.7.5 FOSUNKite Recent Developments
  43. 6.8 Celyad(Pipeline)
  44. 6.8.1 Celyad(Pipeline) Company Information
  45. 6.8.2 Celyad(Pipeline) Business Overview
  46. 6.8.3 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Celyad(Pipeline) CAR T-Cell Therapy Product Portfolio
  48. 6.8.5 Celyad(Pipeline) Recent Developments
  49. 6.9 Cellectis(Pipeline)
  50. 6.9.1 Cellectis(Pipeline) Company Information
  51. 6.9.2 Cellectis(Pipeline) Business Overview
  52. 6.9.3 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Cellectis(Pipeline) CAR T-Cell Therapy Product Portfolio
  54. 6.9.5 Cellectis(Pipeline) Recent Developments
  55. 6.10 CARsgen Therapeutics (Pipeline)
  56. 6.10.1 CARsgen Therapeutics (Pipeline) Company Information
  57. 6.10.2 CARsgen Therapeutics (Pipeline) Business Overview
  58. 6.10.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Portfolio
  60. 6.10.5 CARsgen Therapeutics (Pipeline) Recent Developments
  61. 6.11 Bristol-Myers Squibb
  62. 6.11.1 Bristol-Myers Squibb Company Information
  63. 6.11.2 Bristol-Myers Squibb Business Overview
  64. 6.11.3 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb CAR T-Cell Therapy Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Recent Developments
  67. 6.12 Bluebird Bio(Pipeline)
  68. 6.12.1 Bluebird Bio(Pipeline) Company Information
  69. 6.12.2 Bluebird Bio(Pipeline) Business Overview
  70. 6.12.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Portfolio
  72. 6.12.5 Bluebird Bio(Pipeline) Recent Developments
  73. 6.13 Autolus Therapeutics(Pipeline)
  74. 6.13.1 Autolus Therapeutics(Pipeline) Company Information
  75. 6.13.2 Autolus Therapeutics(Pipeline) Business Overview
  76. 6.13.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
  78. 6.13.5 Autolus Therapeutics(Pipeline) Recent Developments
  79. 6.14 Allogene Therapeutics(Pipeline)
  80. 6.14.1 Allogene Therapeutics(Pipeline) Company Information
  81. 6.14.2 Allogene Therapeutics(Pipeline) Business Overview
  82. 6.14.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
  84. 6.14.5 Allogene Therapeutics(Pipeline) Recent Developments
7 North America
  1. 7.1 North America CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America CAR T-Cell Therapy Market Size by Country (2021-2026)
  3. 7.3 North America CAR T-Cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe CAR T-Cell Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe CAR T-Cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific CAR T-Cell Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific CAR T-Cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America CAR T-Cell Therapy Market Size by Country (2021-2026)
  3. 10.3 South America CAR T-Cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa CAR T-Cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst